Bp PLC Incyte Corp Transaction History

Bp PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$68.67 - $84.02 $319,109 - $390,440	-4,647 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$79.87 - $87.53 $162,455 - $178,036	-2,034 Reduced 30.44%	4,647 $391,000
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $139,496 - $184,417	-1,835 Reduced 21.55%	6,681 $543,000
Q4 2020 Feb 08, 2021	SELL	$80.74 - $97.7 $676,924 - $819,116	-8,384 Reduced 49.61%	8,516 $740,000
Q3 2020 Oct 30, 2020	SELL	$85.07 - $109.69 $119,097 - $153,566	-1,400 Reduced 7.65%	16,900 $1.52 Million
Q2 2020 Aug 05, 2020	BUY	$74.18 - $108.93 $1.36 Million - $1.99 Million	18,300 New	18,300 $1.9 Million
Q1 2020 May 05, 2020	SELL	$63.18 - $85.97 $1.19 Million - $1.62 Million	-18,800 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $58,255 - $69,216	800 Added 4.44%	18,800 $1.4 Million
Q2 2019 Jul 29, 2019	SELL	$73.52 - $88.7 $147,040 - $177,400	-2,000 Reduced 10.0%	18,000 $1.53 Million
Q4 2018 Feb 06, 2019	SELL	$58.5 - $69.94 $175,500 - $209,820	-3,000 Reduced 13.04%	20,000 $1.27 Million
Q2 2018 Jul 30, 2018	BUY	$60.85 - $83.98 $1.4 Million - $1.93 Million	23,000 New	23,000 $1.54 Million
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $1.96 Million - $2.45 Million	-21,000 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$109.15 - $138.27 $2.29 Million - $2.9 Million	21,000	21,000 $2.45 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.